Hinge Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	480.79	390.4	292.73
Revenue Growth (YoY)	-	33.37%	-
Cost of Revenue	106.58	89.81	98.55
Gross Profit	374.21	300.59	194.18
Selling, General & Admin	564.55	227.54	214.64
Research & Development	337.97	97.49	110.06
Operating Expenses	923	325.02	324.69
Operating Income	-548.79	-24.43	-130.51
Interest & Investment Income	20.57	20.57	21.7
Other Non Operating Income (Expenses)	-0.33	0.08	0.27
EBT Excluding Unusual Items	-528.55	-3.78	-108.55
Merger & Restructuring Charges	-1.68	-7.48	-
Pretax Income	-426.05	-11.26	-108.55
Income Tax Expense	0.83	0.68	-0.41
Net Income	-426.88	-11.93	-108.14
Net Income to Common	-426.88	-11.93	-108.14
Shares Outstanding (Basic)	22	14	13
Shares Outstanding (Diluted)	22	14	13
Shares Change (YoY)	-	4.16%	-
EPS (Basic)	-19.47	-0.88	-8.31
EPS (Diluted)	-19.47	-0.88	-8.31
Free Cash Flow	91.17	47.96	-65.89
Free Cash Flow Per Share	4.16	3.54	-5.06
Gross Margin	77.83%	77.00%	66.33%
Operating Margin	-114.14%	-6.26%	-44.59%
Profit Margin	-88.79%	-3.06%	-36.94%
Free Cash Flow Margin	18.96%	12.29%	-22.51%
EBITDA	-546.96	-22.08	-128.39
EBITDA Margin	-113.76%	-5.66%	-43.86%
D&A For EBITDA	1.83	2.35	2.13
EBIT	-548.79	-24.43	-130.51
EBIT Margin	-114.14%	-6.26%	-44.59%
Advertising Expenses	-	37.3	23.8

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q